IBS Private Equity Growth Fund
This fund invests in three funds and will make direct investments in part with the fund managers.
This fund invests in three funds and will make direct investments in part with the fund managers.
The IBS Private Equity Growth Fund is investing 75% of the committed capital in Permira Growth Opportunities Fund II, Keensight Capital Fund VI and Quadriga Capital Fund VI. We will invest the remaining 25% in direct co-investments with these three managers.
The fund pursues a “middle market growth” strategy. This strategy focuses on companies in a relatively opaque market, with lower valuation multiples, lower debt levels and high growth potential.
Furthermore, the fund specifically focuses on sectors that are in a growth phase, partly due to technological or demographic developments. These include technology, healthcare, automation, B2B services, e-commerce and fintech.
The Permira Growth Opportunities II fund targets companies that have recently become profitable with a strong growth profile. The sector focus will be on B2C, digital platforms and consumer services within Europe and North America.
The Keensight Nova VI fund focuses on Western European high-growth companies in the B2B service provider and healthcare sectors. Together with these companies, they aim to realize the potential for international growth, product portfolio expansion and consolidation through organic growth and add-ons.
The Quadriga Capital VI fund invests in companies active in healtchare and industry 4.0. They specialize themselves in niches that benefit from an underlying mega-trend with a strong growth profile where consolidation successes have not yet been made within the DACH+ region.
The prospectuses of the closed-end investment institutions managed for IBS Fund Management B.V. and those of the underlying master investment institutions are available to unitholders upon request (in the secure area of the site and at info@ibsfm.nl).